Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mogamulizumab in previously treated Chinese adults with cutaneous T-cell lymphoma (mycosis fungoides or Sézary syndrome)
CTR20230672Phase 4Completed
- Sponsor
- Kyowa Kirin
- Start
- Jun 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of mogamulizumab in cutaneous T-cell lymphoma (CTCL), mycosis fungoides (MF), Sézary syndrome (SS), sponsored by Kyowa Kirin. Started Jun 2023; status: completed.
02
Drugs
mogamulizumab
03
Conditions
cutaneous T-cell lymphoma (CTCL)mycosis fungoides (MF)Sézary syndrome (SS)
Beyond the preview
Go deeper on CTR20230672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230672.